Serial 87091012
Dead / Cancelled — Cancelled — Section 8 (as of 20 Sept 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87091012
- Registration number
- 5419037
- Mark type
- Design / logo
- Filed
- 01 Jul 2016
- Published for opposition
- 23 May 2017
- Registered
- 06 Mar 2018
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes
- Class 042 — Scientific and technological services: Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services
Owner
- SyneuRx International Corp., Taipei City 110, TW
- SyneuRx International Corp., Taipei City 110, TW
- SyneuRx International Corp., Taipei City 110, TW
Prosecution history
- 20 Sept 2024 — CANCELLED SEC. 8 (6-YR)
- 06 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Dec 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 28 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Dec 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 28 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Dec 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 23 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Mar 2018 — REGISTERED-PRINCIPAL REGISTER